Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Chappell, William H.
868  Ergebnisse:
Personensuche X
?
1

Influences of TP53 and the anti-aging DDR1 receptor in cont..:

Chappell, William H. ; Candido, Saverio ; Abrams, Stephen L....
Aging.  12 (2020)  11 - p. 10194-10210 , 2020
Link: https://doi.org/10.18632..
 
?
2

Therapeutic resistance in breast cancer cells can result fr..:

Steelman, Linda S. ; Chappell, William H. ; Akula, Shaw M....
Advances in Biological Regulation.  78 (2020)  - p. 100758 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Roles of p53, NF-κB and the androgen receptor in controllin..:

Chappell, William H. ; Candido, Saverio ; Abrams, Stephen L....
Advances in Biological Regulation.  69 (2018)  - p. 43-62 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Novel roles of androgen receptor, epidermal growth factor r..:

Chappell, William H. ; Abrams, Stephen L. ; Lertpiriyapong, Kvin...
Advances in Biological Regulation.  60 (2016)  - p. 64-87 , 2016
Link: https://doi.org/10.1016/..
 
?
5

Inhibition of GSK-3β activity can result in drug and hormon..:

Sokolosky, Melissa ; Chappell, William H ; Stadelman, Kristin...
Cell Cycle.  13 (2014)  5 - p. 820-833 , 2014
Link: https://doi.org/10.4161/..
 
?
6

Increased NGAL (Lnc2) expression after chemotherapeutic dru..:

Chappell, William H. ; Abrams, Stephen L. ; Stadelman, Kristin M....
Advances in Biological Regulation.  53 (2013)  1 - p. 146-155 , 2013
Link: https://doi.org/10.1016/..
 
?
7

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: ..:

McCubrey, James A. ; Steelman, Linda S. ; Chappell, William H....
Oncotarget.  3 (2012)  10 - p. 1068-1111 , 2012
Link: https://doi.org/10.18632..
 
?
8

Effects of Ectopic Expression of NGAL on Doxorubicin Sensit..:

Chappell, William H. ; Abrams, Stephen L. ; Montalto, Giuseppe...
Oncotarget.  3 (2012)  10 - p. 1236-1245 , 2012
Link: https://doi.org/10.18632..
 
?
9

Advances in Targeting Signal Transduction Pathways:

McCubrey, James A. ; Steelman, Linda S. ; Chappell, William H....
Oncotarget.  3 (2012)  12 - p. 1505-1521 , 2012
Link: https://doi.org/10.18632..
 
?
10

Novel approaches to target cancer initiating cells–Eliminat..:

McCubrey, James A. ; Abrams, Stephen L. ; Umezawa, Kazuo...
Advances in Biological Regulation.  52 (2012)  1 - p. 249-264 , 2012
Link: https://doi.org/10.1016/..
 
?
11

p53 expression controls prostate cancer sensitivity to chem..:

Chappell, William H. ; Lehmann, Brian D. ; Terrian, David M....
Cell Cycle.  11 (2012)  24 - p. 4579-4588 , 2012
Link: https://doi.org/10.4161/..
 
?
12

Ectopic NGAL expression can alter sensitivity of breast can..:

Chappell, William H. ; Abrams, Stephen L. ; Franklin, Richard A....
Cell Cycle.  11 (2012)  23 - p. 4447-4461 , 2012
Link: https://doi.org/10.4161/..
 
?
13

Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN..:

McCubrey, James A. ; Steelman, Linda S. ; Chappell, William H....
Oncotarget.  3 (2012)  9 - p. 954-987 , 2012
Link: https://doi.org/10.18632..
 
?
14

Involvement of Akt-1 and mTOR in Sensitivity of Breast Canc..:

Sokolosky, Melissa L. ; Stadelman, Kristin M. ; Chappell, William H....
Oncotarget.  2 (2011)  7 - p. 538-550 , 2011
Link: https://doi.org/10.18632..
 
?
15

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rational..:

Chappell, William H. ; Steelman, Linda S. ; Long, Jacquelyn M....
Oncotarget.  2 (2011)  3 - p. 135-164 , 2011
Link: https://doi.org/10.18632..
 
1-15